Barclays CEO CS Venkatakrishnan Diagnosed with Non-Hodgkin Lymphoma
28 Novembre 2022 - 11:07AM
Dow Jones News
By Joe Hoppe
Barclays PLC said Monday that Chief Executive Officer C.S.
Venkatakrishnan has been diagnosed with non-Hodgkin lymphoma, with
treatment expected to last 12 to 16 weeks.
The FTSE 100-listed bank said the cancer has been detected early
and the prognosis is good. Mr. Venkatakrishnan will continue to
actively manage the company during the treatment period.
Write to Joe Hoppe at joseph.hoppe@wsj.com
(END) Dow Jones Newswires
November 28, 2022 04:52 ET (09:52 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Barclays (NYSE:BCS)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Barclays (NYSE:BCS)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024